Loading...
Emerging pharmacological therapies for ARDS: COVID-19 and beyond
ARDS, first described in 1967, is the commonest form of acute severe hypoxemic respiratory failure. Despite considerable advances in our knowledge regarding the pathophysiology of ARDS, insights into the biologic mechanisms of lung injury and repair, and advances in supportive care, particularly ven...
Na minha lista:
| Udgivet i: | Intensive Care Med |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer Berlin Heidelberg
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7352097/ https://ncbi.nlm.nih.gov/pubmed/32654006 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00134-020-06141-z |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|